Ranjan Amit, Scholz Julia, Semmler Torsten, Wieler Lothar H, Ewers Christa, Müller Stefanie, Pickard Derek J, Schierack Peter, Tedin Karsten, Ahmed Niyaz, Schaufler Katharina, Guenther Sebastian
1Institute of Microbiology and Epizootics, Veterinary Faculty, Freie Universität Berlin, Robert-von-Ostertag Str. 7-13, 14163 Berlin, Germany.
2Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.
Gut Pathog. 2018 Jun 15;10:24. doi: 10.1186/s13099-018-0243-z. eCollection 2018.
Extended spectrum beta lactamase (ESBL)-producing extraintestinal pathogenic infections are of global interest because of their clinical and economic impact. The ESBL resistance genes disseminate through plasmids, and are found in successful global lineages such as ST131 and ST648. The carriage of plasmids has been suggested to result in a fitness burden, but recently it was shown that ESBL-plasmids enhanced virulence in pandemic ST131 and ST648 lineages without affecting their fitness. Herein, we investigated the influence of ESBL-plasmids on bacterial competition and serum resistance, both of which are essential characteristics of ExPEC during infections.
Triplets of ESBL-plasmid-carrying wildtype (WT), plasmid-cured variant (PCV) and transformant (T) of five ExPEC strains of ST131 and ST648 were used for bacterial competition experiments with colicin-producing commensal , competitive adhesion experiments and serum survival. In addition, resilience after SDS, acid, osmotic challenges and RNA sequence data were analyzed.
In all five strains tested, ESBL-plasmid carriage did not negatively influence fitness in direct bacterial competition with commensal in vitro. That is, WTs did not show any disadvantages when compared to their isogenic plasmid-free PCV. For one strain we even found the opposite as PCV17433 was out-competed by a commensal strain, which suggests an even protective role of the ESBL-plasmid carried by the WT17433. Similarly, in the serum-resistance experiments, the PCVs of two strains (PCV17433 and PCV17887) were more sensitive to serum, unlike WTs and Ts. The observed inter-strain differences could be explained by the different genetic content of plasmids carried in those strains.
Overall, we found no compelling evidence for an increased burden resulting from the carriage of ESBL-plasmids in the absence of antimicrobial selection pressure in the strains of pandemic ST131 and ST648; rather, the possession of certain ESBL-plasmids was beneficial for some strains in regarding competition fitness and serum survival.
产超广谱β-内酰胺酶(ESBL)的肠外致病性感染因其临床和经济影响而受到全球关注。ESBL耐药基因通过质粒传播,并且在诸如ST131和ST648等全球成功谱系中被发现。有人认为质粒的携带会导致适应性负担,但最近研究表明,ESBL质粒在大流行的ST131和ST648谱系中增强了毒力,而不影响其适应性。在此,我们研究了ESBL质粒对细菌竞争和血清抗性的影响,这两者都是肠外致病性大肠杆菌(ExPEC)在感染期间的基本特征。
使用携带ESBL质粒的ST131和ST648五个ExPEC菌株的野生型(WT)、质粒消除变体(PCV)和转化体(T)的三联体进行与产大肠杆菌素共生菌的细菌竞争实验、竞争性黏附实验和血清存活实验。此外,还分析了在SDS、酸、渗透挑战后的恢复能力以及RNA序列数据。
在所有测试的五个菌株中,携带ESBL质粒在体外与共生菌的直接细菌竞争中对适应性没有负面影响。也就是说,与它们的同基因无质粒PCV相比,WT没有显示出任何劣势。对于一个菌株,我们甚至发现了相反的情况,因为PCV17433被一个共生菌株竞争胜出,这表明WT17433携带的ESBL质粒具有保护作用。同样,在血清抗性实验中,与WT和T不同,两个菌株(PCV17433和PCV17887)的PCV对血清更敏感。观察到的菌株间差异可以通过这些菌株中携带的质粒的不同基因内容来解释。
总体而言,我们没有发现令人信服的证据表明在大流行的ST13俯和ST648菌株中,在没有抗菌选择压力的情况下,携带ESBL质粒会增加负担;相反,拥有某些ESBL质粒对一些菌株在竞争适应性和血清存活方面是有益的。